Avadel Pharmaceuticals plc (AVDL)
NASDAQ: AVDL · Real-Time Price · USD
9.20
-0.09 (-0.97%)
Jun 27, 2025, 4:00 PM - Market closed
Avadel Pharmaceuticals Stock Forecast
Stock Price Forecast
According to 6 professional analysts, the 12-month price target for Avadel Pharmaceuticals stock ranges from a low of $12 to a high of $30. The average analyst price target of $18.17 forecasts a 97.50% increase in the stock price over the next year.
Price Target: $18.17 (+97.50%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 8, 2025.
Analyst Ratings
The average analyst rating for Avadel Pharmaceuticals stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 5 | 5 | 5 | 5 | 4 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 7 | 7 | 7 | 7 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +106.52% | May 8, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +106.52% | Apr 9, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +106.52% | Mar 4, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $21 | Strong Buy | Reiterates | $21 | +128.26% | Mar 4, 2025 |
| Needham | Needham | Strong Buy Reiterates $19 | Strong Buy | Reiterates | $19 | +106.52% | Mar 3, 2025 |
Financial Forecast
Revenue This Year
265.31M
from 169.12M
Increased by 56.88%
Revenue Next Year
344.41M
from 265.31M
Increased by 29.81%
EPS This Year
0.19
from -0.51
EPS Next Year
0.80
from 0.19
Increased by 310.53%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 274.6M | 370.7M | 443.1M | ||
| Avg | 265.3M | 344.4M | 408.5M | ||
| Low | 252.4M | 314.8M | 360.1M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 62.4% | 39.7% | 28.7% | ||
| Avg | 56.9% | 29.8% | 18.6% | ||
| Low | 49.2% | 18.6% | 4.5% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 0.30 | 1.35 | 1.53 |
| Avg | 0.19 | 0.80 | 1.39 |
| Low | 0.10 | 0.45 | 1.26 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | 598.9% | 92.7% |
| Avg | - | 310.5% | 75.2% |
| Low | - | 132.6% | 58.9% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.